Nathan Rice
Stock Analyst at Piper Sandler
(2.97)
# 1,541
Out of 4,981 analysts
56
Total ratings
54.29%
Success rate
8.81%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBIN Merchants Bancorp | Maintains: Overweight | $42 → $41 | $32.27 | +27.05% | 8 | Jul 30, 2025 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $47 → $49 | $39.53 | +23.96% | 4 | Jul 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $115 → $137 | $126.23 | +8.53% | 8 | Jul 21, 2025 | |
| BY Byline Bancorp | Reiterates: Overweight | $34 | $29.05 | +17.06% | 8 | Oct 29, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $73.08 | +1.26% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $133.67 | -37.16% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $131.84 | +49.42% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $18.54 | -51.46% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $648.21 | -32.89% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $297.25 | -21.61% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $32.41 | +156.09% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $18.15 | -17.36% | 1 | Dec 19, 2019 |
Merchants Bancorp
Jul 30, 2025
Maintains: Overweight
Price Target: $42 → $41
Current: $32.27
Upside: +27.05%
First Mid Bancshares
Jul 28, 2025
Maintains: Overweight
Price Target: $47 → $49
Current: $39.53
Upside: +23.96%
Bank First
Jul 21, 2025
Maintains: Neutral
Price Target: $115 → $137
Current: $126.23
Upside: +8.53%
Byline Bancorp
Oct 29, 2024
Reiterates: Overweight
Price Target: $34
Current: $29.05
Upside: +17.06%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $73.08
Upside: +1.26%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $133.67
Upside: -37.16%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $131.84
Upside: +49.42%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $18.54
Upside: -51.46%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $648.21
Upside: -32.89%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $297.25
Upside: -21.61%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $32.41
Upside: +156.09%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $18.15
Upside: -17.36%